A genetic variant of BAFF causes increased production of BAFF and excess B cells and antibodies, and SLE carriers present high rates of arthritis, hematological alterations and nephritis, therefore increasing susceptibility to secondary CVD [143]. The gene discussed is TNFSF13B; the disease is arthritic joint disease.